Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: Halle (Saale), Martin-Luther-Universität Halle-Wittenberg, Dissertation, 2024

Keyword: Epithel
Mesenchym

Event: Veröffentlichung

(where): Halle (Saale)

(who): Universitäts- und Landesbibliothek Sachsen-Anhalt

(when): 2024

Creator: Dorn, Agnes

Contributor: Hüttelmaier, Stefan
Hämmerle, Monika
Pichler, Martin

DOI: 10.25673/116865

URN: urn:nbn:de:gbv:3:4-1981185920-1188254

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Dorn, Agnes
Hüttelmaier, Stefan
Hämmerle, Monika
Pichler, Martin
Universitäts- und Landesbibliothek Sachsen-Anhalt

Time of origin

2024

Other Objects (12)

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Targeting signaling pathways in epithelial ovarian cancer

Involvement of the long noncoding RNA NEAT1 in carcinogenesis

RNA-binding proteins as important regulators of long non-coding RNAs in cancer

Multi-omics in prognosis of hepatocellular carcinoma

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Targeting signaling pathways in epithelial ovarian cancer

Involvement of the long noncoding RNA NEAT1 in carcinogenesis

RNA-binding proteins as important regulators of long non-coding RNAs in cancer

Multi-omics in prognosis of hepatocellular carcinoma

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Targeting signaling pathways in epithelial ovarian cancer

Involvement of the long noncoding RNA NEAT1 in carcinogenesis

RNA-binding proteins as important regulators of long non-coding RNAs in cancer

Multi-omics in prognosis of hepatocellular carcinoma

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Targeting signaling pathways in epithelial ovarian cancer

Involvement of the long noncoding RNA NEAT1 in carcinogenesis

RNA-binding proteins as important regulators of long non-coding RNAs in cancer

Multi-omics in prognosis of hepatocellular carcinoma

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Targeting signaling pathways in epithelial ovarian cancer

Involvement of the long noncoding RNA NEAT1 in carcinogenesis

RNA-binding proteins as important regulators of long non-coding RNAs in cancer

Multi-omics in prognosis of hepatocellular carcinoma

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Targeting signaling pathways in epithelial ovarian cancer

Involvement of the long noncoding RNA NEAT1 in carcinogenesis

RNA-binding proteins as important regulators of long non-coding RNAs in cancer

Multi-omics in prognosis of hepatocellular carcinoma

Related objects

Reset password